Mitchell Sinkler & Starr’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Buy |
692
+70
| +11% | +$28.4K | 0.13% | 128 |
|
|
2025
Q1 | $310K | Hold |
622
| – | – | 0.09% | 133 |
|
|
2024
Q4 | $324K | Buy |
622
+35
| +6% | +$18.2K | 0.09% | 131 |
|
|
2024
Q3 | $363K | Buy |
587
+50
| +9% | +$30.9K | 0.09% | 125 |
|
|
2024
Q2 | $290K | Sell |
537
-26
| -5% | -$14.1K | 0.07% | 129 |
|
|
2024
Q1 | $327K | Sell |
563
-169
| -23% | -$98.2K | 0.08% | 129 |
|
|
2023
Q4 | $389K | Buy |
732
+103
| +16% | +$54.7K | 0.07% | 145 |
|
|
2023
Q3 | $318K | Sell |
629
-14
| -2% | -$7.09K | 0.1% | 97 |
|
|
2023
Q2 | $335K | Hold |
643
| – | – | 0.1% | 117 |
|
|
2023
Q1 | $371K | Sell |
643
-59
| -8% | -$34K | 0.11% | 106 |
|
|
2022
Q4 | $387K | Buy |
702
+44
| +7% | +$24.2K | 0.12% | 106 |
|
|
2022
Q3 | $334K | Buy |
658
+68
| +12% | +$34.5K | 0.13% | 90 |
|
|
2022
Q2 | $321K | Hold |
590
| – | – | 0.12% | 93 |
|
|
2022
Q1 | $348K | Hold |
590
| – | – | 0.11% | 97 |
|
|
2021
Q4 | $394K | Hold |
590
| – | – | 0.12% | 91 |
|
|
2021
Q3 | $337K | Buy |
590
+153
| +35% | +$87.4K | 0.3% | 82 |
|
|
2021
Q2 | $220K | Buy |
+437
| New | +$220K | 0.2% | 102 |
|